Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKinsey
AstraZeneca
Dow
Harvard Business School

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Halofuginone


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Halofuginone?

Halofuginone is an investigational drug.

There have been 5 clinical trials for Halofuginone. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.

The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Sarcoma, Kaposi. The leading clinical trial sponsors are Akashi Therapeutics, Processa Pharmaceuticals, and European Organisation for Research and Treatment of Cancer - EORTC.

There are seven hundred and sixty-eight US patents protecting this investigational drug and nine international patents.

Recent Clinical Trials for Halofuginone
TitleSponsorPhase
HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02Akashi TherapeuticsPhase 2
Open Label Extension Study of HT-100 in Patients With DMDAkashi TherapeuticsPhase 2
Open Label Extension Study of HT-100 in Patients With DMDProcessa PharmaceuticalsPhase 2

See all Halofuginone clinical trials

Clinical Trial Summary for Halofuginone

Top disease conditions for Halofuginone
Top clinical trial sponsors for Halofuginone

See all Halofuginone clinical trials

US Patents for Halofuginone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Halofuginone ⤷  Try it Free Formulations for tailored drug release South Dakota Board of Regents (Pierre, SD) Sanford Health (Sioux Falls, SD) ⤷  Try it Free
Halofuginone ⤷  Try it Free Substituted indole Mcl-1 inhibitors Vanderbilt University (Nashville, TN) ⤷  Try it Free
Halofuginone ⤷  Try it Free Cured gel and method of making ATRIUM MEDICAL CORPORATION (Merrimack, NH) ⤷  Try it Free
Halofuginone ⤷  Try it Free Non-fouling, anti-microbial, anti-thrombogenic graft compositions ARROW INTERNATIONAL, INC. (Wayne, PA) ⤷  Try it Free
Halofuginone ⤷  Try it Free Analyte sensor DexCom, Inc. (San Diego, CA) ⤷  Try it Free
Halofuginone ⤷  Try it Free Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors AbbVie Inc. (North Chicago, IL) ⤷  Try it Free
Halofuginone ⤷  Try it Free Layered medical device with improved adhesion and methods of making Cook Medical Technologies LLC (Bloomington, IN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Halofuginone

Drugname Country Document Number Estimated Expiration Related US Patent
Halofuginone World Intellectual Property Organization (WIPO) WO2016065255 2034-10-23 ⤷  Try it Free
Halofuginone Canada CA2922341 2033-08-28 ⤷  Try it Free
Halofuginone European Patent Office EP3038618 2033-08-28 ⤷  Try it Free
Halofuginone World Intellectual Property Organization (WIPO) WO2015031608 2033-08-28 ⤷  Try it Free
Halofuginone Australia AU2010256930 2029-06-01 ⤷  Try it Free
Halofuginone Australia AU2011311889 2029-06-01 ⤷  Try it Free
Halofuginone Australia AU2015200893 2029-06-01 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKinsey
AstraZeneca
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.